Protective Effect of Wharton's Jelly-derived Mesenchymal Stem Cells on Renal Fibrosis in Rats with Unilateral Ureteral Obstruction
Open Access
- 1 July 2020
- journal article
- research article
- Published by Elsevier BV in European Urology Open Science
- Vol. 20, 48-53
- https://doi.org/10.1016/j.euros.2020.06.004
Abstract
No abstract availableFunding Information
- Cellular and Molecular Research Center of Ahvaz Jundishapur University of Medical Sciences
This publication has 23 references indexed in Scilit:
- Injection of Amniotic Fluid Stem Cells Delays Progression of Renal FibrosisJournal of the American Society of Nephrology, 2012
- Mesenchymal Stem Cells Attenuate Renal Fibrosis Through Immune Modulation and Remodeling Properties in a Rat Remnant Kidney ModelThe International Journal of Cell Cloning, 2009
- Increased E-cadherin expression in the ligated kidney following unilateral ureteric obstructionKidney International, 2009
- Campbell‐Walsh Urology, 9th Edition (E‐dition) ‐ Edited by AJ Wein, LR Kavoussi, AC Novick, AW Partin and CA PetersInternational Journal of Urological Nursing, 2007
- Recent advances into the understanding of mesenchymal stem cell traffickingBritish Journal of Haematology, 2007
- TNF-α neutralization ameliorates obstruction-induced renal fibrosis and dysfunctionAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2007
- Multipotent mesenchymal stem cells reduce interstitial fibrosis but do not delay progression of chronic kidney disease in collagen4A3-deficient miceKidney International, 2006
- Epidemiology and Outcomes of Acute Renal Failure in Hospitalized PatientsClinical Journal of the American Society of Nephrology, 2006
- Stem Cell Approaches for the Treatment of Renal FailurePharmacological Reviews, 2005
- Pluripotency of mesenchymal stem cells derived from adult marrowNature, 2002